Literature DB >> 10334324

Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes.

S Maeda1, M Haneda, H Yasuda, T Tachikawa, K Isshiki, D Koya, M Terada, H Hidaka, A Kashiwagi, R Kikkawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334324     DOI: 10.2337/diabetes.48.2.420

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  5 in total

1.  Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.

Authors:  N Oishi; E Kubo; Y Takamura; K Maekawa; T Tanimoto; Y Akagi
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Aldose reductase (AC)n gene polymorphism in Iranian patients with type 2 diabetic microangiopathy; a case-control study.

Authors:  Mohammad Bagher Hashemi-Soteh; Ali Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Amir Ahmadzadeh Amiri; Soleiman Olfat; Ahmad Ahmadzadeh Amiri
Journal:  Diabetol Int       Date:  2020-06-10

3.  Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.

Authors:  H Liu; Y Luo; T Zhang; Y Zhang; Q Wu; L Yuan; S S M Chung; P J Oates; J Y Yang
Journal:  Diabetologia       Date:  2011-01-27       Impact factor: 10.122

4.  Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase.

Authors:  Yasuhiro Hashimoto; Shin-Ichiro Yamagishi; Hiroki Mizukami; Chihiro Yabe-Nishimura; Sun Woo Lim; H Moo Kwon; Soroku Yagihashi
Journal:  J Diabetes Investig       Date:  2011-04-07       Impact factor: 4.232

Review 5.  Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.

Authors:  Sravya Jannapureddy; Mira Sharma; Gautham Yepuri; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.